Current Opinion in Urology

Papers
(The median citation count of Current Opinion in Urology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Editorial introductions63
Endemic statistical paradoxes in epidemiologic studies distort knowledge on prostate cancer: mitigation and caution of fallacies in prostate cancer causal epidemiological studies45
Research frontiers in urology40
The role of innovations in advancing urologic oncologic patient care38
Prognostic impact of serum testosterone in metastatic hormone-naive prostate cancer: a systematic review and meta-analysis25
Best nonsurgical managements of acute urinary retention: what's new?22
Lithotripsy devices for percutaneous nephrolithotomy (PNL) – new developments21
Exploring the impact of artificial intelligence–enabled decision aids in improving patient inclusivity, empowerment, and education in urology: a systematic review by EAU endourology21
Immunotherapy combinations for metastatic castration-resistant prostate cancer – failed trials and future aspects21
Minimizing overtreatment and maximizing oncologic outcomes in upper tract urothelial carcinoma20
Device-assisted intravesical chemotherapy treatment for nonmuscle invasive bladder cancer: 2022 update20
Tumor-informed circulating tumor DNA in urothelial carcinoma: a promising novel biomarker19
Tissue-based gene expression testing in localized prostate cancer19
The adverse impact of COVID-19 on men's health19
Editorial introductions18
Editorial introductions18
RNA-based urinary assays for non-muscle invasive bladder cancer16
Sustainable practices in hospital and operating theaters16
Editorial introductions16
Systemic immunotherapy for BCG unresponsive nonmuscle-invasive bladder cancer15
Testicular cancer with small metastatic burden: optimal approach in 202415
Upper tract urothelial carcinoma: epidemiology, presentation, and high-risk endemic populations14
Molecular biomarkers to help select neoadjuvant systemic therapy for urothelial carcinoma of the bladder14
Role of cytoreductive radical prostatectomy in men with oligometastatic prostate cancer on molecular imaging13
Optimizing clinical risk stratification of localized prostate cancer13
Gold standard nephroureterectomy, chemoprophylaxis and surveillance in upper tract urothelial carcinoma13
Does radical cystectomy still have a role in BCG-unresponsive nonmuscle invasive bladder cancer?12
Should endoscopic laser excision be offered as the first-line management for patients with eroded mesh? Outcomes of a systematic review of literature12
Risk of dementia associated with the use of anticholinergic medications: a review of recent literature12
Perioperative systemic therapy, current paradigm and ongoing clinical trials in upper tract urothelial cancer11
Oncolytic virus therapy for nonmuscle-invasive bladder cancer: current status and future directions11
Is there a role for metastasis-directed therapy in bladder cancer?11
Sexually transmitted infections and the vaginal microbiome after vaginoplasty10
Guiding treatment decisions in renal cell carcinoma: the role of biomarkers and clinical factors10
Perioperative platform for muscle-invasive bladder cancer trials: designs and endpoints9
All about pulsed thulium:YAG laser: a systematic review from YAU Endourology and EAU Endourology9
Lutetium-177-prostate-specific membrane antigen therapy for prostate cancer: current status and future prospects9
Metabolic syndrome, obesity and cancer risk9
Update on classification of oncocytic neoplasms of the kidney9
Patient-reported outcomes in genital gender-affirming surgery8
Preoperative geriatric assessment of urological patients: a narrative review8
Management of vaginoplasty canal complications8
The role of radiotherapy in pelvic nodal recurrence following definitive treatment for prostate cancer8
Genetics of neuroendocrine prostate cancer: recent progress in genetic understanding is translating into therapeutic opportunities8
Brief update of the new WHO classification for urothelial carcinoma8
Toxicities of taxane-based chemotherapy in prostate cancer7
Latest insights into the pathophysiology of bladder pain syndrome/interstitial cystitis7
Comparison of surgical effectiveness: kidney sparing surgery for upper tract urothelial carcinoma7
Alternatives to whole gland treatment for localized prostate cancer: a review of novel focal therapies7
Preoperative patient optimization for endourological procedures: the current best clinical practice7
Extent of lymph node dissection and impact on survival in radical cystectomy for advanced bladder cancer7
Retrograde intra renal surgery and safety: pressure and temperature. A systematic review7
The role of surgery for locally advanced urothelial cancers7
Are robots the future? A case for robotic pyeloplasty as the gold standard treatment in ureteropelvic junction obstruction7
Decoding germ cell tumours for clinicians7
Sex cord stromal tumors and tumors of the paratestis: new and old entities in a landscape of rare tumors7
Metastasis-directed therapy in oligometastatic and oligoprogressive renal cell carcinoma6
Treatment of adrenocortical carcinoma: oncological and endocrine outcomes6
Editorial introductions6
Innovative systemic therapies for penile cancer6
Implications and effects of COVID-19 on diagnosis and management of prostate cancer6
Liquid biomarkers in prostate cancer: recent advancements and future directions6
Editorial introductions6
MR-guided radiotherapy for prostate cancer: an inevitable transition?6
Percutaneous management of caliceal diverticula: a narrative review6
Medical therapy for male infertility6
Upper tract urothelial carcinoma: conservative management - intraluminal adjuvant therapy, and surveillance6
Lasers for benign prostatic hyperplasia (hybrid, blue diode, TFL, Moses). Which one to choose?6
AI-powered radiomics: revolutionizing detection of urologic malignancies6
Bladder-sparing strategies in patients with clinically localized muscle-invasive bladder cancer6
Advanced sperm tests and impact on clinical male factor management6
Use of genomic markers to improve epidemiologic and clinical research in urology6
Definitions and unmet needs in the management of oligomestatic renal cell carcinoma in the modern era5
Prevention, diagnosis, and treatment of urolithiasis in geriatric patients - differences, similarities and caveats in comparison to the general population5
Association and risk of metabolic syndrome and kidney stone disease: outcomes from a systematic review and meta-analysis5
Digital health innovations in urology: telemedicine, wearables, and mobile applications – a systematic review of literature5
Toxicities of novel androgen receptor pathway inhibitor targeted therapies in advanced prostate cancer5
Cost-effectiveness of serum, urine, and tissue-based prostate cancer biomarkers5
Surgical management of testicular cancer with limited retroperitoneal disease5
Toxicities of radioligand and radioisotope therapy in prostate cancer: a systematic review and meta-analysis5
The carbon footprint of modern imaging5
Ultra-hypofractionation for the treatment of macroscopic prostate bed recurrence: a focus on stereotactic radiotherapy and brachytherapy5
Overlooked and underserved: how healthcare fails men in the pursuit of equity5
Next-gen minimally invasive surgical therapies for benign prostatic hyperplasia: innovations, selection, and best practices- a review from European Association of Urology endourology5
Inflammation and kidney stones: cause and effect?5
Editorial introductions4
Organ storage in renal transplantation4
The urothelial barrier in interstitial cystitis/bladder pain syndrome: its form and function, an overview of preclinical models4
Bladder diverticula management – conservative and surgical outcomes: a narrative review from EAU endourology4
Integration of prostate-specific membrane antigen-PET and multiparametric MRI for gross tumour volume definition in localised and locally advanced prostate cancer treated with image-guided radiotherap4
Advances in ureteral stent technology4
Pelvic pain syndromes4
En-bloc resection of non-muscle invasive bladder cancer: does it really make a difference?4
Editorial: Future of kidney stone management4
Novel intravesical delivery systems for nonmuscle invasive bladder cancer4
Management of stage I testicular cancer4
Role of cytoreductive surgery in the era of immunotherapy4
Metabolic evaluation: is there really a future?4
The role of surgical resection of the primary tumor in metastatic upper tract urothelial carcinoma: a systematic review and meta-analysis4
Editorial introductions4
Small tools, big impact and redefining endourology: the paradigm shift of ureteroscopy for large stones and percutaneous nephrolithotomy for small stones – a literature review4
Medical management of male infertility: now and future4
The role of prophylactic prostatectomy as a primary prevention strategy in high-risk germline mutation carriers4
How to present quality of life outcomes after focal therapy: using validated instruments and novel statistical methods4
Editorial introductions4
Does surgical removal of kidney stones help prevent the recurrence of urinary tract infections? A systematic review4
Detection of urological cancers by the signature of organic volatile compounds in urine, from dogs to electronic noses4
The environmental impacts of anesthesia4
Preclinical models for bladder cancer therapy research4
The use of MRI in urothelial carcinoma4
Endo-technology and its future: where are we heading?4
Transperineal vs. transrectal biopsy to reduce postinterventional sepsis4
What’s in a name? Why differentiation between biochemical recurrence and metastatic prostate cancer matters4
Current position of neuromodulation for bladder pain syndrome/interstitial cystitis4
Editorial introductions4
Leveraging behavioral modification technology for the prevention of kidney stones4
New technologies for nephron-sparing surgery in upper urinary tract cancers4
Integration of novel artificial intelligence tools in pediatric urologic practice4
Genetics of testicular cancer: a review4
Polygenic risk score in prostate cancer3
Impact of lifestyle and environmental factors on fertility3
Diagnostic evaluation for adrenal tumors – What does the urologist need to know about endocrine metabolic work up?3
Radioguided surgery for lymph node metastases in prostate cancer3
Optimal combination therapy for metastatic hormone-sensitive prostate cancer: new evidence, challenges and unanswered questions3
Technical advances in nerve-sparing and continence preservation3
The role of cytoreductive nephrectomy in the immuno-oncological therapy era3
Drug instillation in the management of urinary tract urothelial carcinoma3
Radical cystectomy and women's sexual health – can we do better?3
Reducing financial toxicity in bladder cancer care3
Clinical and pathologic characteristics to select patients for focal therapy or partial gland ablation of nonmetastatic prostate cancer3
The role of radical cystectomy and lymphadenectomy in the management of bladder cancer with clinically positive lymph node involvement3
The role of prostate-specific membrane antigen PET/computed tomography in the management of prostate cancer patients: could we ask for more?3
Advances in preclinical assessment of therapeutic targets for bladder cancer precision medicine3
Simulation training in urology3
Metastasis-directed treatment in kidney cancer3
Urinary continence in high-risk prostate cancer after robot-assisted radical prostatectomy3
The future of laser technology in kidney stones3
En bloc resection of large bladder tumor: is it feasible and reasonable?3
Review of second-generation androgen receptor inhibitor therapies and their role in prostate cancer management3
The spread of retzius-sparing robotic prostatectomy: an update after 10 years3
Artificial intelligence in muscle-invasive bladder cancer: opportunities, challenges, and clinical impact3
Editorial introductions3
Von Hippel–Lindau disease-associated renal cell carcinoma: a call to action3
Recent advancements in personalized management of prostate cancer biochemical recurrence after radical prostatectomy3
Footprints in the scan: reducing the carbon footprint of diagnostic tools in urology3
Editorial introductions3
Optimal systemic therapy in men with low-volume prostate cancer3
Retrograde intrarenal surgery: laser showdown (Ho:YAG vs thulium fiber laser)3
Active surveillance for non-muscle-invasive bladder cancer: fallacy or opportunity?3
Implications of DNA damage repair alterations for the management of prostate cancer3
Where are we in 2024 in the development of materials for surgical treatment of pelvic organ prolapse and stress urinary incontinence?3
Chronic pelvic pain; more than just the bladder3
Artificial intelligence in endourology: emerging technology for individualized care3
Non-invasive central nervous system stimulation to improve bladder and pelvic floor function in the aging population2
The role of nuclear medicine tracers for prostate cancer surgery: from preoperative to intraoperative setting2
Organ-sparing treatment for T1 and T2 penile cancer: an updated literature review2
Clinical and biological markers for risk-stratification of T1 high-grade non-muscle invasive bladder cancer2
Association between male infertility and prostate cancer: a systematic review and meta-analysis: erratum2
Extended pelvic lymph node dissection in muscle invasive bladder cancer2
Editorial: Metastatic prostate cancer: a wealth of data to put into practice2
Current developments in prehabilitation in urologic oncology2
Tumour microenvironment and focal therapy for prostate cancer2
Climate change and urologic care: a challenge for patients and providers2
Artificial urinary sphincter: recent developments and the way forward2
A narrative review on the performance and outcomes of penile and scrotal surgery in the ambulatory setting2
Bacillus Calmette-Guérin unresponsive NMIBC: novel therapies and concepts2
Measuring quality of life in patients with kidney stone disease: is it the future in endourology?2
Should we redefine the Phoenix criteria for biochemical recurrence after primary radiotherapy?2
Micropapillary bladder cancer: an evolving biology2
Recent developments in perioperative combination therapy in muscle-invasive bladder cancer2
Thulium fiber laser in endourology: current clinical evidence2
Definitions, outcomes and perspectives for oligometastatic bladder cancer: towards a standardized terminology2
Changes in practice patterns of nephrolithiasis in the era of the coronavirus disease 2019 pandemic: a review2
The quality of life value in uro-oncological patients2
The role of suction devices in enhancing outcomes of retrograde intrarenal surgery: a narrative review by the YAU urolithiasis and section of EAU endourology2
Orthotopic urinary diversions after radical cystectomy for bladder cancer: lessons learned last decade2
Pembrolizumab in mCRPC – Combination therapies as breakthrough to success?2
Prevention and management of urinary tract infections after cystectomy2
Renal cell carcinoma with inferior vena cava thrombus: did we make progress in oncologic outcomes and complications?2
Editorial introductions2
Electromagnetic-guided puncture: a tool or a tale?2
Molecular research in bladder cancer2
ChatGPT in urology practice: revolutionizing efficiency and patient care with generative artificial intelligence2
Techniques and outcomes of percutaneous tumour ablation for small renal masses2
Salvage radical prostatectomy2
Advancing men's health: insights and innovations2
Trends in outpatient versus inpatient urologic surgery at a university academic medical center2
Metastasectomy in renal cell carcinoma: where are we now?2
Editorial: genetics in urology2
Urological impact of flozins (SGLT2 inhibitors): an EAU Endourology review of risks, side effects and clinical considerations2
Assessing the ripple effects of natural disasters on healthcare systems: a narrative review2
Poly-ADP ribose polymerase inhibitor and androgen receptor signaling inhibitor for all comers for first-line treatment of metastatic castration-resistant prostate cancer: is gene sequencing out?2
Evaluation and management of male genital tract infections in the setting of male infertility: an updated review2
Novel germline mutations for active surveillance and imaging strategies in prostate cancer2
Editorial introduction2
Future directions in transfeminine genital gender-affirming surgery: tissue substitutes and transplant2
0.053816080093384